10x Genomics (TXG) Tops Q1 EPS by 16c, Revenues Beat; Offers FY21 Revenues Mid-Point Guidance Below Consensus
Go back to 10x Genomics (TXG) Tops Q1 EPS by 16c, Revenues Beat; Offers FY21 Revenues Mid-Point Guidance Below Consensus| IT Group, Inc. (NASDAQ: TXG) | Delayed: 30.59 +1.41 (4.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.18 | 52 Week High | $0.00 | |||
| Open | $29.42 | 52 Week Low | $0.00 | |||
| Day High | $30.87 | P/E | N/A | |||
| Day Low | $28.58 | EPS | $0.00 | |||
| Volume | 3,285,840 | |||||

